Back
Intellia Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20
NTLA
Intellia Therapeutics, Inc.
Last Price:
$9.59
Seasonality Move:
-6.88%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and NTLA is experiencing buying pressure, which is a positive indicator for future bullish movement.
Intellia Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.23 | Buy |
| 20-day SMA: | 9.15 | Buy |
| 50-day SMA: | 12.44 | Sell |
| 200-day SMA: | 11.33 | Sell |
| 8-day EMA: | 9.34 | Buy |
| 20-day EMA: | 9.48 | Buy |
| 50-day EMA: | 11.2 | Sell |
| 200-day EMA: | 12.77 | Sell |
Intellia Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.51 | Sell |
| Relative Strength Index (14 RSI): | 47.26 | Sell |
| Chaikin Money Flow: | 1208875 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.45 - 9.51) | Buy |
| Bollinger Bands (100): | (7.99 - 18.91) | Sell |
Intellia Therapeutics, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Intellia Therapeutics, Inc. Stock
Is Intellia Therapeutics, Inc. Stock a Buy?
-
Intellia Therapeutics, Inc. share price is 9.59 while NTLA 8-day simple moving average is 9.23, which is a Buy signal.
-
The stock price of NTLA is 9.59 while Intellia Therapeutics, Inc. 20-day SMA is 9.15, which makes it a Buy.
-
Intellia Therapeutics, Inc. 50-day simple moving average is 12.44 while NTLA share price is 9.59, making it a Sell technically.
-
NTLA stock price is 9.59 and Intellia Therapeutics, Inc. 200-day simple moving average is 11.33, creating a Sell signal.
NTLA Technical Analysis vs Fundamental Analysis
Sell
20
Intellia Therapeutics, Inc. (NTLA)
is a Sell
Is Intellia Therapeutics, Inc. a Buy or a Sell?
-
Intellia Therapeutics, Inc. stock is rated a SellThe current Intellia Therapeutics, Inc. [NTLA] share price is $9.59. The Score for NTLA is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Intellia Therapeutics, Inc. Stock Info
Market Cap:
1.1B
Price in USD:
9.59
Share Volume:
1.5M
Intellia Therapeutics, Inc. 52-Week Range
52-Week High:
28.25
52-Week Low:
5.90
Sell
20
Intellia Therapeutics, Inc. (NTLA)
is a Sell
Intellia Therapeutics, Inc. Share Price Forecast
-
What is the Intellia Therapeutics, Inc. stock price today?The Intellia Therapeutics, Inc. stock price is 9.59 USD today.
-
Will NTLA stock go up or go down?Intellia Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Intellia Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Intellia Therapeutics, Inc. is overvalued.
Is Intellia Therapeutics, Inc. Stock a Buy?
-
Intellia Therapeutics, Inc. share price is 9.59 while NTLA 8-day exponential moving average is 9.34, which is a Buy signal.
-
The stock price of NTLA is 9.59 while Intellia Therapeutics, Inc. 20-day EMA is 9.48, which makes it a Buy.
-
Intellia Therapeutics, Inc. 50-day exponential moving average is 11.20 while NTLA share price is 9.59, making it a Sell technically.
-
NTLA stock price is 9.59 and Intellia Therapeutics, Inc. 200-day simple moving average is 12.77, creating a Sell signal.
Fundamental Analysis of Intellia Therapeutics, Inc.
Is Intellia Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.31 per share, and an increase next year of $0.38 per share.
Technical Analysis of Intellia Therapeutics, Inc.
Should I short Intellia Therapeutics, Inc. stock?
-
NTLA Moving Average Covergence Divergence (MACD) indicator is -0.51, suggesting Intellia Therapeutics, Inc. is a Sell
-
Intellia Therapeutics, Inc. Relative Strength Index (RSI) is 47.26, which suggest Intellia Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Intellia Therapeutics, Inc. is (8.45 - 9.51), which suggest Intellia Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Intellia Therapeutics, Inc. is (7.99 - 18.91), which suggest Intellia Therapeutics, Inc. is a Sell
* Intellia Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.